Scientific reports
Brolucizumab versus aflibercept in treating exudative age-related macular degeneration: a 12-month pro re nata regimen.
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Seigo Yoneyama, Yumi Kotoda, Daphne Viel Tsuru, Kenji Kashiwagi
Published: 202610.1038/s41598-026-34984-x
No abstract available for this study.